St. Jude Medical cardiac valve prosthesis in infants and children: early and intermediate experience

Area of Science:

• Pediatric Cardiology
• Cardiovascular Surgery
• Biomaterials and Medical Devices

Background:

• Pediatric heart valve disease necessitates effective and durable prosthetic solutions.
• The St. Jude Medical valve prosthesis is a mechanical device used for heart valve replacement.
• Assessing the safety and efficacy of prosthetic valves in pediatric populations is crucial.

Purpose of the Study:

• To evaluate the initial clinical performance of the St. Jude Medical valve prosthesis in pediatric patients.
• To assess the safety, efficacy, and complication rates associated with this valve in children undergoing valve replacement.

Main Methods:

• Retrospective review of 14 pediatric patients who received St. Jude Medical valve prostheses.
• Patients' ages ranged from 14 months to 17 years.
• Follow-up included clinical assessment, anticoagulation management (warfarin or aspirin), and postoperative cardiac catheterization in select cases.

Main Results:

• All 14 pediatric patients survived the operation, with no late deaths reported.
• The follow-up period (2 months to 3 years) revealed no valve-related complications, thromboemboli, or hemolysis.
• Postoperative cardiac catheterization in three patients demonstrated satisfactory hemodynamic and angiographic results.

Conclusions:

• The St. Jude Medical valve prosthesis demonstrates initial satisfactory performance in pediatric heart valve replacement.
• The device appears safe and effective in this pediatric cohort, with a notable absence of early complications.
• Further long-term studies are warranted to confirm durability and outcomes in pediatric patients.